Brief: Salarius Pharmaceuticals Issues New U.S. Patent For Next Gen Targeted Protein Degraders

Decoy Therapeutics

05/01/2023 14:07

Jan 5 (Reuters) - Salarius Pharmaceuticals Inc  SLRX.O :
    * SALARIUS PHARMACEUTICALS ANNOUNCES ISSUANCE OF NEW U.S.
PATENT
FOR NEXT-GENERATION TARGETED PROTEIN DEGRADERS
    * SALARIUS-CLAIMS COVER COMPOSITION OF MATTER FOR MOLECULAR
GLUE
DEGRADERS INCLUDING CO'S PRECLINICAL CEREBLON-BINDING
COMPOUND,SP-3204,THROUGH SEPT 2037

Source text for Eikon:  ID:nGNX3NPs0B 
Further company coverage:  SLRX.O 
 ((Reuters.Briefs@thomsonreuters.com;))